Stock Events

Stock Events

Search...

Apellis Pharmaceuticals (1JK.F) Q4 2023 Earnings

27FebConfirmed

Q4 2023

-0.67

-0.67

-0.67

-0.67

Details

Expected EPS

-0.67401903882

Actual EPS

-0.6733374

Surprise EPS

0

Surprise Percent

+0.1%

Description

Apellis Pharmaceuticals (1JK.F) has reported earnings of -0.6733374 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.